For example, mass cytometry has added CD4, CD45RA, and CD11c as potential markers for RA diagnosis, along with the functional markers p-p38 and CD86, yet the application of these findings in treating diverse patient populations is still evolving (3). This evidence concerns the gene CD4 and rheumatoid arthritis.